Coagulation factor VII levels in uremic patients and theirs influence factors.
- Author:
Jun FANG
1
;
Ling-Hui XIA
;
Wen-Ning WEI
;
Shan-Jun SONG
Author Information
1. Institute of Hematology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. fangjunfj@163.net
- Publication Type:Journal Article
- MeSH:
Adult;
Aged;
Factor VII;
analysis;
Female;
Humans;
Male;
Middle Aged;
Myocardial Infarction;
blood;
etiology;
Renal Dialysis;
Risk Factors;
Uremia;
blood;
complications;
therapy
- From:
Journal of Experimental Hematology
2004;12(6):730-732
- CountryChina
- Language:Chinese
-
Abstract:
This study was aimed to investigate coagulation factor VII level in uremic patients with chronic renal failure and to explore theirs influence factors. The plasma levels of coagulation factor VII were detected in 30 uremic patients with chronic renal failure before and after hemodialysis for 1 month, the factor VII activity (FVII:C) was determined by one-stage coagulation method, while activated factor VII (FVIIa) was measured by one-stage coagulation method using recombinant soluble tissue factor, and factor VII antigen was detected by ELISA. The results showed that: (1) The FVIIa, FVII:C and FVIIAg levels in chronic uremic patients before hemodialysis were 4.00 +/- 0.86 microg/L, (148.5 +/- 40.4)% and (99.8 +/- 21.1)% respectively, which were significantly increased, as compared with healthy controls [2.77 +/- 1.02 microg/L, (113.1 +/- 33.0)% and (73.7 +/- 18.3)% respectively, P < 0.05]. (2) After hemodialysis the FVIIa, FVII:C and FVIIAg levels in uremic patients significantly enhanced to 5.56 +/- 1.45 microg/L, (200.8 +/- 68.7)% and (124.1 +/- 19.3)% respectively (P < 0.05). (3) The abnormal increase of coagulation factor VII was positively correlated with levels of blood uria nitrogen and serum creatinine before hemodialysis but not after hemodialysis. It is concluded that the enhanced levels of coagulation factor VII in chronic uremic patients suggested abnormal activated state, herperactivity and elevated production of factor VII which correlated with renal functional injury. The abnormality of factor VII in uremia may be aggravated by hemodialysis. Coagulation factor (FVII) may be a risk factor for cardiovascular events in uremic patients who especially had been accepted long-term hemodialysis.
